X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28408) 28408
Newspaper Article (10088) 10088
Newsletter (3987) 3987
Magazine Article (432) 432
Trade Publication Article (161) 161
Book Chapter (130) 130
Dissertation (68) 68
Transcript (67) 67
Publication (49) 49
Web Resource (39) 39
Book / eBook (18) 18
Book Review (6) 6
Streaming Video (5) 5
Conference Proceeding (4) 4
Reference (4) 4
Government Document (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
statins (36737) 36737
humans (16400) 16400
cholesterol (14941) 14941
male (9916) 9916
cardiovascular disease (9608) 9608
female (9072) 9072
medical research (7633) 7633
middle aged (7305) 7305
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (7228) 7228
aged (6579) 6579
studies (6568) 6568
risk factors (6290) 6290
research (5947) 5947
heart attacks (5860) 5860
cardiac & cardiovascular systems (5472) 5472
cardiovascular agents (4777) 4777
drug therapy (4677) 4677
atherosclerosis (4469) 4469
lipids (4348) 4348
prevention (4142) 4142
atorvastatin (4058) 4058
mortality (4041) 4041
care and treatment (4035) 4035
statin (3890) 3890
risk (3864) 3864
simvastatin (3825) 3825
statin therapy (3818) 3818
pharmacology & pharmacy (3814) 3814
cardiovascular diseases (3731) 3731
treatment outcome (3490) 3490
diabetes (3443) 3443
adult (3427) 3427
analysis (3398) 3398
therapy (3217) 3217
animals (3212) 3212
medicine, experimental (2888) 2888
low density lipoproteins (2874) 2874
health aspects (2804) 2804
hypercholesterolemia (2728) 2728
inflammation (2565) 2565
cardiology (2563) 2563
coronary heart disease (2555) 2555
peripheral vascular disease (2545) 2545
medicine, general & internal (2533) 2533
low density lipoprotein (2440) 2440
cardiovascular (2437) 2437
coronary-heart-disease (2426) 2426
patients (2417) 2417
clinical trials (2401) 2401
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (2297) 2297
cholesterol, ldl - blood (2281) 2281
drugs (2267) 2267
stroke (2263) 2263
abridged index medicus (2234) 2234
c-reactive protein (2173) 2173
disease (2150) 2150
cardiac patients (2085) 2085
pravastatin (2047) 2047
health risk assessment (2006) 2006
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (1996) 1996
cardiovascular-disease (1988) 1988
dosage and administration (1953) 1953
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (1950) 1950
aged, 80 and over (1919) 1919
metaanalysis (1792) 1792
internal medicine (1788) 1788
myocardial-infarction (1780) 1780
hypertension (1770) 1770
cardiovascular diseases - prevention & control (1769) 1769
hypercholesterolemia - drug therapy (1660) 1660
retrospective studies (1643) 1643
medicine (1622) 1622
anticholesteremic agents - therapeutic use (1594) 1594
medicine & public health (1588) 1588
lipoproteins (1580) 1580
cancer (1578) 1578
usage (1543) 1543
atorvastatin calcium (1540) 1540
time factors (1514) 1514
rosuvastatin (1465) 1465
antilipemic agents (1411) 1411
safety (1359) 1359
prospective studies (1355) 1355
risk assessment (1352) 1352
follow-up studies (1334) 1334
efficacy (1326) 1326
complications and side effects (1306) 1306
drug therapy, combination (1304) 1304
density-lipoprotein cholesterol (1303) 1303
dyslipidemia (1278) 1278
triglycerides (1258) 1258
primary prevention (1257) 1257
biomarkers - blood (1249) 1249
events (1238) 1238
enzymes (1233) 1233
heart (1227) 1227
acute coronary syndromes (1218) 1218
endocrinology & metabolism (1191) 1191
drug dosages (1186) 1186
breast cancer (1148) 1148
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (42963) 42963
Russian (203) 203
German (197) 197
Spanish (133) 133
French (129) 129
Japanese (107) 107
Portuguese (55) 55
Hungarian (24) 24
Korean (21) 21
Polish (21) 21
Chinese (18) 18
Czech (17) 17
Swedish (11) 11
Turkish (8) 8
Norwegian (7) 7
Ukrainian (5) 5
Serbian (3) 3
Dutch (2) 2
Italian (2) 2
Persian (2) 2
Slovak (2) 2
Arabic (1) 1
Croatian (1) 1
Danish (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 12, pp. 1119 - 1131
... subsequently found that beneficial outcomes after statin therapy relate to both a reduction in cholesterol level and inflammation inhibition. 7 – 11 Yet, to date... 
no | C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 04/2006, Volume 295, Issue 13, pp. 1556 - 1565
Journal Article
by Fulcher, Jordan and O'Connell, Rachel and Voysey, Merryn and Emberson, Jonathan and Blackwell, Lisa and Mihaylova, Borislava and Simes, John and Collins, Rory and Kirby, Adrienne and Colhoun, Helen and Braunwald, Eugene and La Rosa, John and Pedersen, T.R and Tonkin, Andrew and Davis, Barry and Sleight, Peter and Franzosi, Maria Grazia and Baigent, Colin and Keech, Anthony and De Lemos, J and Braunwald, E and Blazing, M and Murphy, S and Downs, J.R and Gotto, A and Clearfield, M and Holdaas, H and Gordon, D and Davis, B and Koren, M and Dahlöf, B and Poulter, N and Sever, P and Knopp, R.H and Fellström, B and Holdaas, H and Jardine, A and Schmieder, R and Zannad, F and Goldbourt, U and Kaplinsky, E and Colhoun, H.M and Betteridge, D.J and Durrington, P.N and Hitman, G.A and Fuller, J and Neil, A and Wanner, C and Krane, V and Sacks, F and Moyé, L and Pfeffer, M and Hawkins, C.M and Braunwald, E and Kjekshus, J and Wedel, H and Wikstrand, J and Barter, P and Tavazzi, L and Maggioni, A and Marchioli, R and Tognoni, G and Franzosi, M.G and Maggioni, A and Bloomfield, H and Robins, S and Collins, R and Armitage, J and Parish, S and Peto, R and Sleight, P and Pedersen, T.R and Ridker, P.M and Holman, R and Meade, T and Simes, J and MacMahon, S and Marschner, I and Tonkin, A and Shaw, J and Serruys, P.W and Nakamura, H and Knatterud, G and Furberg, C and Byington, R and Macfarlane, P and Cobbe, S and Ford, I and Murphy, M and Blauw, G.J and Packard, C and Shepherd, J and Kjekshus, J and Pedersen, T and Wilhelmsen, L and Braunwald, E and Cannon, C and Murphy, S and Collins, R and Armitage, J and ... and unav and Cholesterol Treatment Trialists' (CTT) Collaboration and Cholesterol Treatment Trialists' C
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9976, pp. 1397 - 1405
Journal Article
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2014, Volume 311, Issue 18, pp. 1870 - 1882
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 25, pp. 2387 - 2397
... – 4 Intensive statin therapy, as compared with moderate-dose statin therapy, incrementally lowers LDL cholesterol levels and rates of nonfatal cardiovascular events. 5... 
no | CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 06/2006, Volume 113, Issue 24, pp. 2826 - 2834
.... However, the remodeling response during plaque-stabilizing therapy and its relationship to markers of lipid metabolism and inflammation are incompletely understood... 
Intravascular ultrasonography | Arteriosclerosis | Imaging | Inflammation | Remodeling | Statins | Plaque | C-REACTIVE PROTEIN | plaque | remodeling | CARDIAC & CARDIOVASCULAR SYSTEMS | intravascular ultrasonography | ENLARGEMENT | PLAQUE VULNERABILITY | RANDOMIZED CONTROLLED-TRIAL | imaging | CORONARY-ARTERY | arteriosclerosis | inflammation | STATIN THERAPY | statins | DISEASE | GROWTH | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | PROGRESSION | Coronary Vessels - diagnostic imaging | Single-Blind Method | Hyperlipidemias - blood | Prospective Studies | Follow-Up Studies | Vasculitis - physiopathology | Cholesterol - blood | Coronary Vessels - physiopathology | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Vasculitis - etiology | Adaptation, Physiological - drug effects | Ultrasonography, Interventional | Male | Cardiac Catheterization | Coronary Artery Disease - physiopathology | Adult | Cholesterol, LDL - blood | Female | C-Reactive Protein - analysis | Hyperlipidemias - physiopathology | Pyrroles - therapeutic use | Pravastatin - therapeutic use | Hyperlipidemias - complications | Coronary Artery Disease - etiology | Models, Cardiovascular | Hyperlipidemias - drug therapy | Risk Factors | Atorvastatin Calcium | Coronary Angiography | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cholesterol, HDL - blood | Aged
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2013, Volume 62, Issue 10, pp. 909 - 917
Journal Article